{reportSlug=global-moyamoya-disease-market, reportId=126829, mktKeyword=Moyamoya disease, cagr=0.00, publishDate=Nov 2022, priceOption2=7500, reportTitle=Moyamoya disease Comprehensive Study by Type (Ischemic, Hemorrhagic, Epileptic, Other), Treatment (Non-Surgical {Anti-seizure medications, and Calcium channel blockers}, Surgical {Vascular bypass surgery, and Cerebral Revascularization }), Age Group (5 to 10 years in children, 30 to 50 years in adults, Other), Diagnosis (Cerebral angiogram, Magnetic resonance imaging (MRI), Magnetic resonance angiography (MRA), Computed tomography (CT), Positron emission tomography (PET), Electrocardiography ECG, Transcranial Doppler ultrasound), Surgical Procedure (Indirect {Encephalomyosynangiosis (EMS), Encephaloduroarteriosynangiosis (EDAS)}, Direct {Suturing of a scalp blood vessel, the superficial temporal artery}), Distribution channel (Hospital, Surgical Centers, Diagnostic clinics, Others) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=212, priceOption1=3750, forecastYr=2027, noOfPages=215, reportKey=126344, breadcrum=Global Moyamoya disease Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Nov 2022
215 Pages
63 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries